Feline Bocavirus

Overview and Taxonomy of Feline Bocavirus

Feline bocavirus (FBoV) represents a relatively recently discovered yet globally significant pathogen within the feline enteric virome. First identified in 2012 from domestic cats in Hong Kong, FBoV is a non-enveloped, linear, single-stranded DNA virus belonging to the family Parvoviridae, subfamily Parvovirinae, genus Bocaparvovirus [1, 7, 10]. The genus Bocaparvovirus encompasses a diverse array of viruses infecting both human and animal hosts, including the well-characterized human bocavirus (HBoV), canine bocavirus (CBoV), and various ungulate bocaviruses. The taxonomic classification of FBoV has evolved rapidly with the accumulation of genomic sequence data, and the virus is currently subdivided into three distinct species or genotypes: FBoV-1, FBoV-2, and FBoV-3 [1, 3, 11, 12]. This tripartite classification is supported by phylogenetic analyses based on complete genome sequences and individual gene regions, particularly the non-structural protein 1 (NS1) gene, which is the most conserved and widely used target for molecular detection and genotyping [2, 11]. The demarcation criteria for these genotypes are stringent; nucleotide sequence identities between genotypes are typically less than 80–85% across the full genome, while within-genotype identities often exceed 95% [10, 11]. For instance, early characterization of FBoV strains from Northeast China revealed that the virus could be divided into two distinct lineages with nucleotide identity differences exceeding 20–30% between lineages, a genetic distance that firmly supports species-level separation [10].

The genomic organization of FBoV is characteristic of bocaparvoviruses and is a defining feature of the genus. The genome is approximately 5.0–5.5 kilobases in length and contains four major open reading frames (ORFs) arranged in the order 5′-NS1-ORF4-NP1-VP1/VP2-3′ [8, 18]. This architecture distinguishes bocaparvoviruses from other parvoviruses, which typically lack the NP1 gene and the additional ORF4. The NS1 gene encodes a non-structural protein essential for viral DNA replication, helicase activity, and transcriptional regulation. The NP1 gene is a hallmark of the Bocaparvovirus genus; its protein product is involved in the processing of viral mRNA and the regulation of capsid gene expression, and it serves as a critical target for diagnostic assays due to its high conservation within genotypes [5, 14]. The VP1 and VP2 genes encode the viral capsid proteins, which are responsible for host cell receptor binding, tissue tropism, and immune recognition. The VP1/VP2 region exhibits the highest degree of genetic variability among FBoV strains, and this diversity is a major driver of antigenic variation and potential immune escape [14]. The presence of ORF4, which is unique to certain bocaparvoviruses, encodes a protein of unknown function, though it is hypothesized to play a role in host range determination or pathogenesis [18].

Phylogenetic analyses of FBoV strains from diverse geographic regions have consistently demonstrated the co-circulation of multiple genotypes within feline populations. Studies from China, Thailand, Japan, Vietnam, and the United States have all documented the presence of FBoV-1, FBoV-2, and FBoV-3, often with complex patterns of co-infection [2, 3, 11, 12, 14]. FBoV-1 appears to be the most prevalent and globally distributed genotype, frequently detected in both diarrheic and asymptomatic cats [11, 13]. For example, a comprehensive survey of 197 fecal samples from cats in Northeast China identified 51 FBoV-positive samples (25.9%), of which 35 were FBoV-1, 12 were FBoV-2, and 4 were co-infections of FBoV-1 and FBoV-2 [11]. Similarly, a study in Harbin, China, examining 289 blood samples from healthy cats, reported an overall FBoV prevalence of 12.1%, with genotypes 1 and 3 co-circulating [3]. In Japan, FBoV was detected in 9.9% of rectal swabs from 101 cats, with all three identified strains clustering within genotype 2 [12]. More recently, a prospective investigation in Thailand utilizing species-specific quantitative PCR (qPCR) assays revealed that FBoV-1 and FBoV-2 were detected in multiple cats from a single household, with co-infection observed in 55.6% of cats [1]. These findings underscore the remarkable genetic diversity and widespread distribution of FBoV, suggesting that the virus is an endemic component of the feline virome across continents.

The evolutionary dynamics of FBoV are shaped by both genetic drift and recombination, with the latter playing a particularly significant role in generating genomic diversity. Recombination events have been documented across all three FBoV genotypes, with breakpoints frequently localized within the NP1 and VP1/VP2 genes, suggesting that these regions may serve as recombination hotspots [8, 14]. A landmark study analyzing 19 complete coding sequences of FBoVs from Thai cats provided the first evidence of natural recombination in FBoV-2 and FBoV-3, in addition to confirming recombination in FBoV-1 [14]. The recombination breakpoints were identified as intragenic and intraspecies, meaning they occurred within a single gene and between strains of the same genotype, respectively. Notably, no interspecies recombination (e.g., between FBoV and CBoV) was detected, indicating that recombination is constrained by species-specific barriers [14]. In another study from Anhui Province, China, inter- and intra-genotype recombination events were identified among five complete FBoV genomes, further supporting the role of recombination as a key evolutionary mechanism [8]. Additionally, recombination was detected in the NS1 gene of a Thai FBoV-1 strain isolated from a moribund cat with hemorrhagic enteritis, highlighting the potential for recombination to generate strains with altered pathogenic properties [7]. Selection pressure analyses consistently indicate that FBoV genomes are predominantly under purifying (negative) selection, which acts to eliminate deleterious mutations and maintain the integrity of essential protein-coding genes [3, 8, 14]. However, positive selection sites have been identified in the VP1/2 gene of FBoV-1 and FBoV-3, suggesting that adaptive evolution may occur in regions involved in host immune interactions [14]. Codon usage bias analyses further reveal that FBoV-1 and FBoV-3 are continuously evolving toward adaptation to their feline hosts, with selection pressure being the primary driver of codon usage patterns [8].

The taxonomic relationship of FBoV to other bocaparvoviruses is an area of active investigation, particularly regarding the potential for cross-species transmission. The detection of canine bocavirus 1 (CBoV1) in a fecal sample from an asymptomatic domestic cat in Northeast China provides compelling evidence that cats can serve as carriers of bocaviruses typically associated with dogs [18]. The nearly complete genome of this feline-derived CBoV1 strain, designated 17CC0312, shared over 90.3% nucleotide sequence identity with CBoV1 reference sequences and clustered within the CBoV1 lineage 3 in phylogenetic analyses [18]. This finding raises important questions about the host range of bocaparvoviruses and the potential for interspecies transmission in multi-pet households or environments where dogs and cats cohabitate. Conversely, FBoV has not been detected in humans, and there is no evidence to suggest zoonotic potential. The World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) do not currently list FBoV as a notifiable or zoonotic pathogen, and its significance is confined to feline medicine. However, the close genetic relationship between FBoV and other bocaparvoviruses, including human bocavirus, underscores the need for continued surveillance to monitor for any potential host range expansion.

The clinical significance of FBoV infection remains an area of intense debate and ongoing research. While FBoV has been consistently associated with gastrointestinal disease, particularly diarrhea and hemorrhagic enteritis, its role as a primary pathogen is not definitively established [7, 10, 11]. The virus is frequently detected in healthy, asymptomatic cats, suggesting that it may be a commensal member of the feline enteric virome that only causes disease under specific conditions, such as co-infection with other enteric pathogens or in immunocompromised hosts [2, 12]. For instance, a study in Northern Vietnam detected FBoV in only 4 of 166 fecal samples (2.41%), with one from a diarrheic cat and three from healthy cats, and no co-infections with other enteric viruses were observed [2]. In contrast, a study in Japan found that the number of FBoV-positive cases was significantly greater in cats with diarrhea than in those without, particularly in kittens aged 1 to 2 months, suggesting an age-dependent susceptibility to disease [13]. The association between FBoV and severe enteritis was first reported in Northeast China, where a novel FBoV strain, HRB2015-LDF, was identified from a cat with fatal hemorrhagic enteritis [10]. Subsequent outbreak investigations in Thailand provided the first pathological evidence of FBoV-1 involvement in hemorrhagic enteritis, with viral DNA detected in multiple tissues, including intestinal cells and vascular endothelium, and viral nucleic acid localized by in situ hybridization in areas of necrosis [7]. These findings, while suggestive of a pathogenic role, are complicated by the frequent co-detection of other enteric viruses, such as feline panleukopenia virus (FPV), feline coronavirus (FCoV), and feline astrovirus (FeAstV) [1, 5, 15, 16]. Indeed, co-infection rates are exceptionally high; a meta-transcriptomic study of the enteric virome in cats with feline panleukopenia revealed that FBoV-2 and FBoV-3 were detected significantly more frequently in FPV-cases than in healthy controls, and co-infections with FCoV and Mamastrovirus 2 were common [15]. This has led to the hypothesis that FBoV may act synergistically with other pathogens to exacerbate disease severity, rather than acting as a sole etiological agent [7, 19].

Beyond the gastrointestinal tract, FBoV has been implicated in systemic infections, including neurological disease. A groundbreaking study investigating the presence of FBoV in brain samples from 78 cats with neurological deficits and 41 healthy cats detected FBoV DNA in 6.41% of the neurologically affected cats, with FBoV-1 identified in four cases and FBoV-3 in one case [4]. Histopathological examination revealed multifocal neuronal vacuolation in the cerebrum and brain stem of 80% of FBoV-positive cases, and eosinophilic inclusion-like materials were found within the nuclei of glial cells in the FBoV-3 positive case. In situ hybridization confirmed the presence of FBoV DNA in oligodendroglia and vacuolated neurons, and transmission electron microscopy visualized FBoV-3 virions in the nuclei of glial cells [4]. These findings provide compelling evidence that FBoV is a neurotropic virus capable of causing neuronal pathology, expanding the clinical spectrum of FBoV-associated disease beyond enteritis. The detection of FBoV DNA in multiple lymph nodes and intestines of the same positive cases suggests that the virus may disseminate from the gastrointestinal tract to the central nervous system via hematogenous or lymphatic routes [4]. This neurotropic potential mirrors that of other parvoviruses, such as canine parvovirus type 2, which can cause encephalitis in dogs, and underscores the need for FBoV to be considered in the differential diagnosis of feline neurological disorders of unknown etiology.

The shedding dynamics of FBoV are critical for understanding its transmission and persistence in feline populations. Longitudinal studies using species-specific qPCR assays have revealed that FBoV shedding can persist well beyond the resolution of clinical signs. In a prospective investigation of naturally infected cats in multi-cat households, FBoV-1 and FBoV-2 were detected in fecal samples for 10–14 days after the cessation of diarrhea, and one hospital-resident cat continued to shed FBoV-1 for up to 65 days [1]. This prolonged shedding period has significant implications for infection control, particularly in shelters, catteries, and multi-cat households, where the risk of transmission is high. The virus is shed in feces, and likely also in respiratory secretions, though the latter route has not been systematically investigated. The high viral loads detected by qPCR, which varied significantly over time and across sample types, indicate that FBoV can replicate to high titers in the gastrointestinal tract, facilitating efficient fecal-oral transmission [1]. The persistence of shedding in asymptomatic cats further complicates control efforts, as these animals may serve as unrecognized reservoirs of infection. The development of sensitive and specific diagnostic tools, including TaqMan-based qPCR assays and multiplex PCR methods, has greatly enhanced the ability to monitor shedding dynamics and quantify viral loads in clinical samples [5, 6, 9, 16, 17]. These assays are essential for both research and clinical diagnostics, enabling the differentiation of FBoV genotypes and the detection of co-infections with other enteric viruses. The establishment of such molecular tools has been a cornerstone of FBoV research, allowing for large-scale epidemiological surveys and detailed investigations of viral pathogenesis.

Molecular Pathogenesis and Genotypic Diversity of Feline Bocavirus

Molecular Architecture and Genomic Organization

Feline bocavirus (FBoV) is a non-enveloped, linear single-stranded DNA virus belonging to the genus Bocaparvovirus within the family Parvoviridae [1, 10]. The viral genome, approximately 5,000–5,500 nucleotides in length, exhibits the characteristic bocaparvovirus organization comprising three primary open reading frames (ORFs): NS1 (non-structural protein 1), NP1 (a distinct bocavirus-specific nuclear phosphoprotein), and VP1/VP2 (the overlapping capsid proteins) [10, 11]. Some strains also harbor an additional ORF4 of unknown function, typically positioned between NS1 and NP1 [18]. The NS1 gene encodes a multifunctional protein essential for viral DNA replication, transcriptional regulation, and helicase activity, while VP1/VP2 constitute the structural components of the icosahedral capsid. The NP1 protein is a hallmark of bocaviruses, distinguishing them from other parvoviruses, and plays critical roles in capsid assembly, mRNA processing, and evasion of host antiviral responses [11, 14]. The presence of these discrete genomic modules underpins the virus’s capacity for both lytic replication in dividing cells and persistent infection in non-dividing or slowly dividing tissues, a feature that has profound implications for pathogenesis.

Based on complete genome sequence analyses and phylogenetic clustering of the NS1 and VP1/VP2 genes, FBoV is currently classified into three distinct genotypes, FBoV-1, FBoV-2, and FBoV-3, which exhibit inter-genotypic nucleotide identities as low as 64–68% in the NS1 region, indicative of substantial genetic divergence [2, 10-12]. Complete genome sequencing of Thai, Chinese, and Japanese isolates has confirmed that inter-genotypic differences exceed 20–30% across the entire genome, fulfilling the species demarcation criteria for the Bocaparvovirus genus [10, 14]. This genotypic framework is essential for understanding the diverse pathogenic potentials and tissue tropisms exhibited by different FBoV lineages.

Molecular Pathogenesis: Cellular Tropism and Tissue Pathology

The molecular pathogenesis of FBoV infection is a multifaceted process that extends well beyond the originally described enteric disease. Early investigations established a strong association between FBoV-1 and gastroenteritis, with viral DNA detected by in situ hybridization (ISH) localized to intestinal crypt epithelial cells, villous enterocytes, and vascular endothelial cells of the intestinal mucosa and serosa [7]. This distribution suggests that FBoV-1 gains initial entry via the gastrointestinal epithelium, thereafter disseminating hematogenously to infect secondary lymphoid organs, including mesenteric lymph nodes, where viral replication occurs within necrotic areas [7]. The tropism for rapidly dividing intestinal crypt cells is a hallmark shared with other parvoviruses, accounting for the severe hemorrhagic enteritis observed in some outbreaks [7, 10]. Importantly, the detection of FBoV-1 DNA in multiple parenchymal organs, including lymph nodes, spleen, liver, and lungs, in naturally infected cats confirms that systemic viremia is a consistent feature of active infection, even in the absence of overt clinical signs [4, 7].

The paradigm of FBoV as a purely enteric pathogen was fundamentally challenged by the demonstration of neurotropism in cats presenting with neurological deficits. In a landmark study, FBoV-1 and FBoV-3 DNA were amplified from the cerebrum and brainstem of cats with neurological signs, with ISH revealing viral nucleic acid within oligodendroglia and vacuolated neurons [4]. Histopathological examination disclosed multifocal neuronal vacuolation predominantly in the cerebrum and brainstem, along with eosinophilic intranuclear inclusion-like materials within glial cells in an FBoV-3-positive case [4]. Transmission electron microscopy confirmed the presence of complete virions within the nuclei of glial cells, providing definitive ultrastructural evidence of productive infection [4]. This neuroinvasion is believed to occur via hematogenous seeding across the blood–brain barrier or via retrograde axonal transport from peripheral nerve endings, although the precise molecular mechanisms remain to be elucidated. The detection of FBoV DNA in multiple lymph nodes and intestinal tissues of the same neurological cases suggests that neurotropic strains retain the capacity for parenteral and enteral infection, underscoring the dual-tissue tropism of these viruses [4].

At the cellular level, FBoV infection triggers a robust inflammatory response characterized by histiocytic and lymphoplasmacytic infiltration in affected organs [4, 7]. The viral NP1 protein is thought to modulate host innate immunity by interfering with interferon signaling pathways, thereby facilitating viral persistence and spread [14]. Furthermore, the demonstration of viral DNA in vascular endothelium [7] implicates endothelial cell infection as a driver of vascular permeability, contributing to hemorrhagic manifestations and edema observed in severe cases.

Shedding Dynamics and Viral Persistence

Longitudinal qPCR-based monitoring of naturally infected cats has illuminated the temporal dynamics of FBoV shedding and its implications for transmission. Viral loads exhibit marked variation over time and across sample types (feces, rectal swabs, and oropharyngeal swabs), with FBoV-1 and FBoV-2 detected for 10–14 days after the resolution of clinical signs in most animals [1]. In one remarkable case, a hospital-resident cat continued to shed FBoV-1 for up to 65 days after clinical recovery, indicating the potential for prolonged subclinical shedding and sustained environmental contamination [1]. This prolonged shedding is of particular concern in multi-cat households, shelters, and cattery environments, where it facilitates cryptic transmission and may underlie the high endemicity observed in such settings.

The detection of FBoV DNA in both diarrheic and nondiarrheic cats, with prevalence rates as high as 33.3% in symptomatic animals versus 17.4% in healthy controls, confirms that asymptomatic carriage is common [11]. Deep sequencing of the enteric virome in cats with feline panleukopenia (FPL) has further revealed that Carnivore bocaparvovirus 3 (FBoV) and Carnivore bocaparvovirus 4 (FBoV-2) are significantly enriched in FPL-affected cats compared to healthy controls, suggesting that FBoV co-infection may exacerbate disease severity or be facilitated by immunosuppression induced by FPV [15].

Genotypic Diversity, Recombination, and Global Molecular Epidemiology

The genotypic landscape of FBoV is characterized by remarkable diversity and a continuously expanding repertoire of recombinant strains. Phylogenetic analyses of partial NS1 and complete genomic sequences from isolates across Asia, Europe, and the Americas have consistently resolved three major clades corresponding to FBoV-1, FBoV-2, and FBoV-3, with further subdivision into distinct sublineages within each clade [2, 3, 8, 11, 12]. In China, co-circulation of FBoV-1 and FBoV-2 is widespread, with FBoV-1 generally predominating [3, 11]. In contrast, studies from Japan and Thailand have reported comparable frequencies of all three genotypes, reflecting regional differences in transmission dynamics [12, 14]. The first molecular evidence of FBoV in Vietnam documented co-circulating genotype I and II strains, with nucleotide identities among Vietnamese isolates ranging from 64.68% to 99.57%, indicative of both inter- and intra-genotypic variability [2].

A critical driver of FBoV genetic diversity is natural recombination. Recombination events have been detected across multiple geographic settings, particularly in the NP1 and VP1/2 genes, suggesting that these regions serve as recombination hotspots [7, 8, 14]. The first description of natural recombination in FBoV-1 occurred in Thai strains, where a recombination breakpoint within the NS1 gene was identified, and subsequent analyses have extended these observations to RBoV-2 and FBoV-3 [7, 14]. Intragenic recombination is responsible for the emergence of mosaic genomes that may possess altered antigenicity, tissue tropism, or replication kinetics, thereby facilitating immune escape and adaptation to new host environments. Notably, no evidence of interspecies recombination between FBoV and other bocaparvoviruses has been detected, indicating that species barriers remain intact at the recombination level [14].

Selection pressure analyses consistently indicate that purifying (negative) selection is the dominant evolutionary force acting on FBoV coding sequences, with the VP1/2 capsid gene under the strongest constraint, likely due to its critical role in virion structure and stability [3, 8, 14]. However, positive selection sites have been identified in FBoV-1 and FBoV-3, particularly within regions encoding the NP1 protein and the VP1 unique region, which may confer adaptive advantages in specific host microenvironments [14]. These observations suggest that while the virus is predominantly constrained by functional requirements, episodic positive selection permits the emergence of novel variants with enhanced fitness.

Cross-Species Transmission and the Feline Bocavirome

The detection of canine bocavirus 1 (CBoV-1) in a domestic cat with no clinical signs highlights the potential for bocavirus spillover across carnivore species [18]. The complete genome sequence of this feline-derived CBoV-1 strain shared >90.3% nucleotide identity with canine reference strains, indicating that the cat likely acquired the virus through interspecies transmission, possibly via contaminated fomites or direct contact with infected dogs [18]. This finding raises important questions regarding the role of cats as accidental hosts or potential reservoirs for bocaviruses of other carnivores and underscores the need for expanded surveillance across multi-host environments.

Metagenomic surveys of the feline enteric virome have revealed that FBoV constitutes a core component of the eukaryotic virome in both healthy and diseased cats, frequently co-occurring with feline coronavirus (FCoV), feline astrovirus, feline panleukopenia virus, and feline kobuvirus [15, 16]. The prevalence of FBoV in such surveys ranges from 12% to 25% depending on the population, with co-infection rates exceeding 50% in some cohorts [1, 11, 15]. This frequent co-occurrence suggests that FBoV may act as a copathogen that modulates disease expression, a hypothesis supported by the observation that FPL cases have significantly higher loads of FBoV-2 compared to healthy controls [15]. Global surveillance efforts, particularly in regions with dense cat populations such as China, Thailand, Japan, Vietnam, and Italy, have demonstrated that FBoV infection is endemic worldwide, with no evidence of geographic compartmentalization, likely facilitated by international movement of cats [2, 3, 12, 14, 20].

The absence of FBoV in some populations, for example, a Turkish study examining cats with ulcerative stomatitis found no FBoV-positive individuals, suggests that prevalence may be mediated by local ecological factors, including population density, management practices, and co-circulating pathogens [20]. Nevertheless, the sustained circulation of multiple genotypes and the ongoing generation of recombinant strains mandate continuous molecular surveillance to monitor the emergence of potentially more pathogenic variants. The development and refinement of multiplex PCR and quantitative real-time PCR assays, now capable of detecting and differentiating all three FBoV genotypes with limits of detection as low as 40 copies per reaction, provide robust tools for such surveillance [1, 6, 9, 17, 21].

Epidemiology and Global Distribution of Feline Bocavirus

Feline bocavirus (FBoV) is a linear, single-stranded DNA virus belonging to the genus Bocaparvovirus within the family Parvoviridae, and it has emerged as a globally distributed pathogen since its initial identification in 2012 [1, 3, 10]. The virus is currently classified into three distinct species, FBoV-1, FBoV-2, and FBoV-3, each exhibiting a broad but uneven geographic distribution across multiple continents [1, 3, 4, 12]. Understanding the epidemiological landscape of FBoV is critical for elucidating its transmission dynamics, pathogenic potential, and role in feline disease, particularly as it has been implicated in both gastrointestinal and systemic infections, including neurologic deficits [4, 7, 11].

Global Prevalence and Geographic Distribution

The available epidemiological data, derived predominantly from molecular surveillance studies, indicate that FBoV circulates widely among domestic cat populations across Asia, Europe, North America, and Australia, although the true global prevalence remains to be comprehensively mapped [1, 2, 12, 15]. Early reports identified FBoV in the United States, Japan, Hong Kong, and Portugal, establishing its presence in disparate geographic regions [11, 12]. Subsequent investigations have significantly expanded the known distribution, with robust epidemiological data emerging from several Asian countries, particularly China, Thailand, Vietnam, and Japan [2, 3, 8, 12, 14].

In China, numerous cross-sectional and surveillance studies have documented FBoV across multiple provinces, including Northeast China (Heilongjiang, Jilin, Liaoning), Eastern China (Anhui, Shandong), and Northern China (Harbin) [3, 5, 8, 10, 11, 22]. Prevalence rates in these studies vary considerably depending on the sampled population, diagnostic methodology, and clinical status of the cats. For instance, a study in Harbin using blood samples from 289 apparently healthy cats reported an overall FBoV prevalence of 12.1% [3]. In Northeast China, a more comprehensive analysis of 197 fecal samples, drawn from both diarrheic and normal cats, yielded a markedly higher positivity rate of 25.9% (51/197), with a significantly greater prevalence observed in cats with diarrhea (33.3%) compared to asymptomatic individuals (17.4%) [11]. A separate investigation in the same region detected FBoV in 2.78% of samples from cats with severe enteritis, indicating that prevalence can fluctuate based on disease severity and sampling strategy [10]. Furthermore, a multiplex PCR survey of 197 fecal samples from domestic cats in Northeast China identified FBoV DNA in 51 samples, equating to a positivity rate of 25.9% for FBoV as part of a broader evaluation of enteric viruses [5]. These data collectively suggest that FBoV is endemic in Chinese cat populations, with FBoV-1 consistently reported as the most prevalent genotype [11].

Beyond China, FBoV has been detected in other Asian nations, albeit often at lower prevalence. In Northern Vietnam, a 2022–2023 survey of 166 fecal samples from domestic cats across four provinces reported an FBoV detection rate of only 2.41% (4/166), with both genotype I (FBoV-1) and genotype II (FBoV-2) co-circulating [2]. In Japan, an early study of rectal swabs from 101 cats found an FBoV infection rate of 9.9%, with the detected strains clustering closely with the FBoV-2 POR1 strain based on NS1 gene analysis [12]. More recent Japanese data from rescued stray cats across multiple regions corroborate the circulation of FBoV types 1, 2, and 3, with a significantly higher number of positive cases observed in cats displaying diarrhea symptoms, particularly among kittens aged 1 to 2 months [13]. In Thailand, extensive molecular characterization has revealed that all three FBoV species (FBoV-1, -2, and -3) are endemic, with Thai strains often showing close genetic relatedness to those previously identified in Thailand and China [14]. One particularly noteworthy study on shedding dynamics in Thai multi-cat households demonstrated FBoV-1 and FBoV-2 in multiple cats, with coinfection observed in over half of the animals and viral shedding persisting for 10–14 days after clinical resolution, and up to 65 days in one hospital-resident cat [1].

Outside of Asia, epidemiological data remain comparatively sparse. The initial discovery of FBoV in Hong Kong, along with subsequent reports from the USA and Portugal, confirm its presence in both Eastern and Western hemispheres [11, 12]. Importantly, a study in Turkey analyzing clinical samples from cats with ulcerative stomatitis found no evidence of FBoV infection, suggesting that the virus may be absent from certain geographic regions or that its prevalence is influenced by local host and environmental factors [20]. Similarly, a metagenomic analysis of the enteric virome in Australian shelter cats detected Carnivore bocaparvovirus 3 and 4 (corresponding to feline bocavirus species) in both healthy cats and those infected with feline panleukopenia virus, underscoring the global ubiquity of FBoV and its frequent co-circulation with other enteric pathogens [15]. The differential prevalence observed across studies, ranging from less than 3% in Vietnam to over 25% in Northeast China, likely reflects true geographic variation but is also influenced by differences in sampling frames, diagnostic sensitivity (e.g., conventional PCR versus quantitative PCR), and the health status of the study populations [2, 6, 11, 17].

Genotypic Diversity and Co-circulation

The three recognized FBoV genotypes exhibit distinct but overlapping geographic distributions. FBoV-1 is the most widely reported and appears to be the predominant genotype across China, Thailand, and Japan [11, 12, 14]. FBoV-2 and FBoV-3 are also circulating extensively, with FBoV-2 detected in Japan, Thailand, and China, and FBoV-3 identified in Thailand, Japan, and China [1, 3, 4, 13, 14]. Co-circulation of multiple genotypes within the same geographic region is a consistent finding. For example, in Harbin, China, both FBoV-1 and FBoV-3 were found co-circulating among healthy cats sampled from blood [3]. In Northeast China, FBoV-1 and FBoV-2 were detected concurrently, with the former being more prevalent [11]. The study in Northern Vietnam reported co-circulation of FBoV genotypes I and II [2]. Genotypic diversity is further evidenced by phylogenetic analyses, which have shown that strains from different geographic origins, such as China, Hong Kong, and Thailand, often cluster together, suggesting cross-border transmission and shared viral gene pools [2, 3, 14]. The high genetic heterogeneity within genotypes, particularly in the NP1 and VP1/2 genes, has been linked to recombination events, which serve as a key driver of FBoV evolution [14]. Recombination breakpoints have been identified across all three species, with NP1 and VP1/2 identified as potential hotspots for intragenic recombination [14]. In addition, recombination analysis of strains from China has revealed both inter- and intra-genotype recombination events, further contributing to genetic diversity and potentially facilitating immune evasion or altered tropism [3, 8].

Epidemiological Associations with Clinical Disease and Co-infections

Establishing a definitive causal relationship between FBoV infection and specific clinical syndromes has been challenging due to the high frequency of co-infections with other enteric pathogens and the detection of the virus in both symptomatic and asymptomatic animals [2, 11, 15, 22]. Nevertheless, accumulating evidence supports a significant association between FBoV detection and gastrointestinal disease, particularly diarrhea. Multiple studies have demonstrated a statistically higher prevalence of FBoV in cats with diarrhea compared to healthy controls [11, 13]. One study found a positive rate of 33.3% in diarrheic cats versus 17.4% in normal cats [11]. Japanese data further indicated that the number of FBoV-1 and FBoV-2 positive cases was significantly greater in cats with diarrhea, with kittens aged 1–2 months exhibiting a particularly high rate of clinical signs [13]. The association is not exclusive to enteric disease; FBoV-1 and FBoV-3 have been detected in brain tissues of cats with neurologic deficits, with FBoV DNA identified in the cerebrum, brain stem, and, to a lesser extent, cerebellum of affected animals [4]. Histopathological findings in these cases included multifocal neuronal vacuolation and eosinophilic inclusion-like materials in glial cell nuclei, suggesting a neurotropic potential for FBoV [4].

Co-infections are the rule rather than the exception in FBoV epidemiology. FBoV is frequently detected alongside other enteric viruses, including feline coronavirus (FCoV), feline panleukopenia virus (FPV/FPLV), feline astrovirus (FeAstV), and feline kobuvirus (FeKoV) [1, 15, 16, 22, 23]. In Thai multi-cat households, FCoV was frequently co-detected with FBoV in all households [1]. In China, co-infection rates are high, with FBoV-positive samples often also positive for FPV, FeAstV, and FeKoV [5, 16, 21, 23]. A study on parvovirus in cats from Eastern Shandong found that among parvovirus-positive cats, co-infections with FCoV, FeAstV, and FBoV were common [22]. Metagenomic analysis of the enteric virome in Australian cats showed that Carnivore bocaparvovirus 4 (FBoV-2) was detected significantly more frequently in FPV-cases than in healthy controls, suggesting a potential synergistic interaction between these parvoviruses [15]. This synergy has been hypothesized to exacerbate clinical severity, as seen in outbreaks of hemorrhagic enteritis where dual infection with FPLV and FBoV-1 was associated with unusually severe presentations [7]. Viral tropism studies have confirmed FBoV-1 DNA in intestinal cells, vascular endothelium, and multiple lymph nodes, supporting the concept of systemic spread and a contributory role in enteric disease [7].

Viral Shedding and Transmission Dynamics

Understanding shedding patterns is crucial for implementing effective control measures, particularly in multi-cat environments such as shelters and catteries. Longitudinal studies employing quantitative PCR (qPCR) have revealed significant variation in viral load over time and across sample types, with shedding persisting well beyond the resolution of clinical signs [1]. In one prospective investigation, FBoV-1 and FBoV-2 detection persisted for 10–14 days after clinical recovery in most cats, and one hospital-resident cat continued to shed FBoV-1 for up to 65 days [1]. This prolonged shedding period highlights the potential for extended transmission risk within crowded housing situations, even after cats appear clinically normal. The presence of FBoV DNA in both feces and multiple tissues (including lymph nodes and intestines) suggests that transmission can occur via the fecal-oral route and potentially through direct contact with contaminated fomites [4, 7]. The high prevalence of FBoV in multi-cat households and shelters emphasizes the need for stringent hygiene and isolation protocols to curtail spread.

Methodological Considerations and Surveillance Gaps

The variability in reported prevalence underscores the importance of diagnostic methodology. The development of sensitive quantitative PCR assays, including SYBR Green I-based and TaqMan-based qPCR, has significantly improved detection limits compared to conventional PCR [6, 9, 17]. For instance, a TaqMan qPCR for FBoV-1 achieved a detection limit of 4.57 × 10¹ copies/μL, a 100-fold improvement over conventional PCR [17]. A SYBR Green I-based qPCR for FBoV-1 established a detection limit of 3.87 × 10¹ copies/μL, again substantially more sensitive than conventional PCR [6]. Duplex real-time PCR assays have also been developed for simultaneous detection of FPV and FBoV-1, facilitating the diagnosis of co-infections [9]. The adoption of these advanced molecular tools is essential for accurate epidemiological surveillance, particularly for detecting low-level shedding and subclinical infections. Multiplex approaches capable of differentiating FBoV from other common feline enteric pathogens, such as FPV and FeAstV, are now available and should be incorporated into routine diagnostic workflows [5, 16]. Despite these advances, significant gaps remain in our understanding of FBoV epidemiology, particularly regarding its seroprevalence, the role of environmental reservoirs, and the potential for cross-species transmission to other carnivores. The detection of canine bocavirus 1 in a domestic cat in China suggests that interspecies transmission events may occur, although their epidemiological significance is unknown [18]. Future surveillance efforts should prioritize comprehensive, multi-country longitudinal studies using standardized molecular methods to fully characterize the global distribution, genotypic diversity, and clinical impact of feline bocavirus.

Clinical Manifestations and Disease Associations in Domestic Cats

Feline bocavirus (FBoV) infection in domestic cats presents a remarkably heterogeneous clinical spectrum, ranging from completely asymptomatic carriage to severe, life-threatening systemic disease. The delineation of this clinical landscape has been progressively refined through a combination of natural infection studies, outbreak investigations, and experimental molecular diagnostics. Critically, the pathogenicity of FBoV appears to be strain-dependent, modulated by host factors such as age and immune status, and substantially influenced by the presence of concurrent viral infections. The clinical significance of FBoV must therefore be understood not as a monofactorial disease but as a complex, multifactorial syndrome.

Gastrointestinal Manifestations: The Predominant Clinical Phenotype

The most consistently reported and best-characterized clinical presentation of FBoV infection is acute gastroenteritis. Multiple independent epidemiological investigations across geographically disparate regions have documented a statistically significant association between FBoV detection and diarrheal disease. In Northeast China, a seminal study of 197 cats revealed an FBoV prevalence of 25.9%, with a markedly higher positive rate observed in cats with diarrhea (33.3%) compared to asymptomatic controls (17.4%), providing early epidemiological evidence for a pathogenic role [11]. This association has been reinforced by investigations in Japan, where concurrent analysis of multiple parvoviruses demonstrated that FBoV types 1 and 2 were significantly more prevalent in cats exhibiting diarrhea than in those without gastrointestinal signs, with kittens aged one to two months being particularly vulnerable [13]. The clinical syndrome associated with FBoV-induced enteritis can be severe. In Thailand, FBoV-1 was identified as the causative agent in outbreaks of hemorrhagic enteritis among household cats, a presentation clinically indistinguishable from feline panleukopenia but occurring in the absence of FPV infection in some cases [7]. Affected cats presented with profuse, bloody diarrhea, profound lethargy, and anorexia, with some cases progressing to a fatal outcome. The pathological basis for this hemorrhagic phenotype has been elucidated through detailed histopathological and in situ hybridization studies, which localized FBoV-1 nucleic acid to intestinal epithelial cells and, critically, to the vascular endothelium of the intestinal mucosa and serosa [7]. This vascular tropism provides a mechanistic explanation for the hemorrhagic diathesis observed clinically, as viral replication within endothelial cells disrupts microvascular integrity, leading to focal hemorrhage and ischemic necrosis of the intestinal mucosa.

The clinical course of FBoV-associated gastroenteritis is not invariably acute and self-limiting. Longitudinal sampling studies have revealed that viral shedding can persist far beyond the resolution of clinical signs. In a prospective investigation of naturally infected cats in multi-cat households, FBoV-1 and FBoV-2 were detected by quantitative PCR for 10 to 14 days after the complete resolution of diarrheal symptoms, and one hospital-resident cat continued to shed FBoV-1 for up to 65 days [1]. This prolonged shedding has profound implications for both clinical management and infection control. It suggests that convalescent cats, while appearing clinically normal, may serve as a persistent source of environmental contamination and onward transmission, particularly problematic in multi-cat environments such as shelters, breeding catteries, and veterinary hospitals. The viral loads quantified during this post-clinical shedding phase were not negligible, indicating that these animals remain infectious [1]. Clinicians must therefore consider extending isolation protocols beyond the symptomatic period, and reliance on clinical resolution as a surrogate for infectivity cessation is demonstrably inadequate.

Systemic and Neurologic Involvement: Expanding the Pathogenic Spectrum

Beyond the gastrointestinal tract, a growing body of evidence indicates that FBoV is capable of causing systemic infection with direct involvement of the central nervous system (CNS). This recognition represents a paradigm shift in understanding FBoV pathogenesis, as bocaviruses in other species, including humans, have been associated with neurologic disease, but the neurotropic potential of FBoV in cats was unknown until recently. A landmark investigation screened brain tissues from 78 cats presenting with neurologic deficits of unknown etiology and detected FBoV DNA in 6.41% of cases [4]. The neurologic signs observed in these cats were diverse and non-specific, including altered mentation, proprioceptive deficits, ataxia, and seizure activity. Molecular characterization identified FBoV-1 in four cases and FBoV-3 in one case, demonstrating that multiple genotypes possess neuroinvasive capacity [4]. Histopathological examination of the FBoV-positive brains revealed a consistent pattern of multifocal neuronal vacuolation, predominantly affecting the cerebrum and brain stem, with 80% of positive cases exhibiting this distinctive lesion. In the FBoV-3 positive case, eosinophilic inclusion-like material was observed within the nuclei of glial cells, a finding reminiscent of parvoviral nuclear pathology in other systems [4]. Definitive proof of neurotropism was provided by dual-labeling immunohistochemistry and in situ hybridization, which co-localized FBoV DNA specifically within oligodendroglia and vacuolated neurons. Transmission electron microscopy confirmed the presence of intact FBoV-3 virions within the nuclei of glial cells, unequivocally demonstrating active viral replication within the CNS parenchyma [4]. This finding establishes FBoV as a bona fide neurotropic pathogen in cats and adds it to the differential diagnosis for feline neurologic disease, particularly when accompanied by gastrointestinal signs or when other common causes (e.g., FIP, toxoplasmosis, neoplasia) have been excluded.

The systemic dissemination of FBoV is further evidenced by its detection in multiple tissues beyond the intestine and brain. In cats with neurologic involvement, viral DNA was also detected in multiple lymph nodes and intestinal tissues, suggesting a dual route of infection encompassing both enteral and parenteral pathways [4]. This is consistent with the concept of a primary enteric infection followed by hematogenous spread, a pathogenesis model well-established for other parvoviruses. Indeed, in cases of severe FBoV-1-associated hemorrhagic enteritis, viral DNA was identified in a wide array of tissues, including lymph nodes, spleen, liver, and kidneys, indicative of systemic viremia [7]. The hematogenous route likely facilitates neuroinvasion, with the virus crossing the blood-brain barrier or perhaps entering via infected leukocytes.

Coinfections and Synergistic Pathogenesis

A defining feature of FBoV clinical disease is its frequent occurrence in the context of mixed infections with other enteric and systemic pathogens. The clinical expression of FBoV infection is therefore often amplified by synergistic interactions with co-infecting viruses, most notably feline panleukopenia virus (FPV), feline coronavirus (FCoV), and feline astrovirus (FeAstV). The most clinically consequential synergy appears to be between FBoV-1 and FPV. In the Thai outbreaks of hemorrhagic enteritis, dual infection with FPV and FBoV-1 was hypothesized to produce a more severe clinical presentation than either virus alone, potentially explaining the unusually high morbidity and mortality observed [7]. The mechanisms underlying this synergism are likely multifactorial. FPV, by infecting and destroying rapidly dividing crypt epithelial cells and leukocytes, induces profound immunosuppression and mucosal barrier disruption. This creates a permissive environment for FBoV-1 replication and facilitates its access to the vascular endothelium, thereby exacerbating the hemorrhagic component of the disease. Conversely, FBoV-induced endothelial damage may enhance the systemic dissemination of FPV. The high frequency of FBoV detection in FPV-positive cats reported in virome studies supports this interaction, with Carnivore bocaparvovirus 4 (FBoV-2) and Carnivore bocaparvovirus 3 (FBoV-1) detected significantly more frequently in FPV-infected cats than in healthy controls [15].

Coinfection with FCoV is also extremely common. In the longitudinal study of multi-cat households, FCoV was frequently co-detected in all households alongside FBoV, and in one household, 55.6% of cats harbored both FBoV-1 and FBoV-2 concurrently with FCoV [1]. The clinical implications of this co-detection are complex. FCoV is itself highly prevalent and often asymptomatic, but its presence may modulate the immune response and influence the outcome of FBoV infection. While a direct causal link has not been established, the frequent co-occurrence suggests that these viruses may share transmission routes or that infection with one predisposes to infection with the other.

Asymptomatic Infection and Subclinical Carriage

A substantial proportion of FBoV infections are subclinical, a finding that complicates our understanding of the virus's true disease burden and has major implications for its epidemiology. In Vietnam, FBoV was detected in 2.41% of fecal samples from domestic cats, but only one of the four positive cats had diarrhea; the remaining three were completely healthy [2]. Similarly, in Harbin, China, a prevalence of 12.1% was found in blood samples collected from apparently healthy cats [3]. These findings are not anomalous; they are consistent with the epidemiology of other bocaviruses and parvoviruses, where mild or inapparent infections are the rule rather than the exception. The factors that determine whether an infection will remain subclinical or progress to overt disease are not fully defined but likely include viral load, genotype, host age, immune competence, and the presence of co-infections. The high prevalence of subclinical carriage underscores the importance of FBoV as a silent reservoir in the feline population, ensuring its continued circulation and posing a constant risk of transmission to susceptible individuals, particularly young kittens or immunocompromised cats in high-density housing situations. The World Organisation for Animal Health (WOAH) recognizes the importance of subclinical carriers in the epidemiology of viral pathogens, and FBoV fits this paradigm perfectly, highlighting the need for surveillance programs that do not rely solely on clinical case identification.

Diagnostics and Quantitative Detection of Feline Bocavirus

The accurate detection and quantification of feline bocavirus (FBoV) are foundational to elucidating its epidemiology, pathogenesis, and clinical significance. Since its initial identification in 2012, diagnostic capabilities have evolved from conventional endpoint PCR to highly sensitive quantitative real-time PCR (qPCR) assays capable of discriminating among the three recognized genotypes (FBoV-1, -2, and -3), as well as multiplex platforms that simultaneously detect co-infecting enteric pathogens. The development of these tools has been driven by the recognition that FBoV is globally distributed, frequently detected in both diarrheic and asymptomatic cats, and often present as part of a complex enteric virome [1, 11, 15]. Consequently, diagnostic approaches must be sufficiently robust to differentiate FBoV genotypes, quantify viral load across sample types, and integrate with broader surveillance for pathogens such as feline panleukopenia virus (FPV), feline coronavirus (FCoV), and feline astrovirus (FeAstV).

Conventional and Genotyping PCR

Early molecular detection of FBoV relied upon conventional PCR (cPCR) targeting conserved regions of the non-structural NS1 gene. This approach has been used extensively in prevalence studies worldwide, including investigations in China, Japan, Thailand, Vietnam, and Portugal [2, 3, 11, 12]. The NS1 gene is favored for broad-spectrum detection because it contains regions that are relatively conserved across bocavirus species, yet possesses sufficient variability to permit genotyping via amplicon sequencing. In the landmark study by Yi et al. (2018) in Northeast China, cPCR targeting different FBoV genotypes revealed an overall prevalence of 25.9% (51/197) in fecal samples, with FBoV-1 identified in 35 samples, FBoV-2 in 12, and co-infections of both in four animals [11]. Subsequent phylogenetic analysis of partial NS1 sequences from these samples enabled discrimination between genotype I and II clusters, establishing the foundation for genotypic surveillance.

Similarly, Dong et al. (2025) employed NS1-targeted cPCR to screen 166 fecal samples from domestic cats in Northern Vietnam, yielding a 2.41% prevalence (4/166) and the identification of both FBoV genotype I (three strains) and genotype II (one strain) [2]. The detection limit of cPCR, however, is notably inferior to qPCR. Wang et al. (2021) reported that conventional cPCR for FBoV-1 had a detection limit of 3.87 × 10³ copies/μL, compared to 3.87 × 10¹ copies/μL for a SYBR Green I-based qPCR assay, representing a 100-fold improvement in analytical sensitivity [6]. This disparity underscores the limitation of cPCR for quantifying low-level shedding, particularly in asymptomatic carriers or during the convalescent phase of infection. Nonetheless, cPCR combined with Sanger sequencing remains an essential tool for genotyping and phylogenetic inference, as it provides the amplicons necessary for characterizing circulating strains and detecting recombination events, which have been documented in FBoV-1, -2, and -3 from Thailand, China, and Hong Kong [7, 14].

Quantitative Real-Time PCR: SYBR Green I and TaqMan Platforms

The development of quantitative real-time PCR (qPCR) has revolutionized FBoV detection by enabling precise viral load measurement, enhanced sensitivity, and high throughput. Two principal chemistries have been employed: SYBR Green I-based detection, which relies on intercalating dye binding to double-stranded DNA, and TaqMan probe-based detection, which utilizes sequence-specific fluorescent probes for greater specificity.

Wang et al. (2021) established a SYBR Green I-based qPCR for FBoV-1 targeting the NS1 gene, with a detection limit of 3.87 × 10¹ copies/μL, excellent reproducibility (intra-assay CV ≤ 0.98%; inter-assay CV ≤ 1.42%), and a clinical detection rate of 7.0% (9/128) compared to 4.7% (6/128) by cPCR in feline fecal samples [6]. The melting curve analysis revealed a single peak at 83.0°C, confirming specificity, while no cross-reactivity was observed with other feline viruses, including FPV, feline herpesvirus, feline calicivirus, and FCoV. A further refinement of this technology was the development of a SYBR Green I-based duplex real-time PCR for simultaneous detection of FPV and FBoV-1, capitalizing on distinct melting temperatures (86°C for FBoV-1 and 77.5°C for FPV) [9]. This duplex assay demonstrated detection limits of 3.836 × 10¹ copies/μL for FBoV-1 and 2.907 × 10¹ copies/μL for FPV, with a co-infection detection rate of 3.03% (4/132) in clinical samples, which was significantly more sensitive than traditional PCR methods [9].

For enhanced specificity and the ability to perform multiplex detection without melting curve interference, TaqMan probe-based assays have been developed. Wang et al. (2020) designed a TaqMan qPCR for FBoV-1 targeting a conserved NS1 region, achieving a detection limit of 4.57 × 10¹ copies/μL and 100-fold greater sensitivity than cPCR [17]. Crucially, this assay demonstrated no cross-reaction with FBoV-2 or FBoV-3, confirming its genotype-specific nature, a critical feature given that mixed infections are common [1, 17]. The inter-assay variability (0.27%–0.45%) and intra-assay variability (0.18%–1.00%) indicated outstanding reproducibility. Lohavicharn et al. (2025) extended this approach by developing three separate singleplex TaqMan qPCR assays for FBoV-1, FBoV-2, and FBoV-3, enabling the first characterization of viral load dynamics in naturally infected cats [1]. These assays were deployed in a longitudinal study across three multi-cat households, revealing that viral loads varied significantly over time and across sample types (feces, oral swabs, and rectal swabs). Notably, FBoV-1 shedding persisted for 10–14 days after resolution of clinical signs in most cats, and one hospital-resident cat continued to shed FBoV-1 for up to 65 days [1]. This level of temporal and quantitative resolution is impossible with conventional PCR and underscores the value of species-specific qPCR for understanding transmission risk and environmental persistence.

Multiplex PCR and Real-Time Platforms

Given that FBoV frequently co-infects with other enteric viruses, particularly FPV, FeAstV, and FCoV, there has been substantial investment in multiplex assays that simultaneously detect and differentiate multiple pathogens. Zhang et al. (2019) developed a multiplex conventional PCR (mPCR) targeting the NP1 gene of FBoV (465 bp), the VP2 gene of FPV (237 bp), and the RdRp gene of FeAstV (645 bp) [5]. This assay demonstrated a detection limit of 2.25–4.04 × 10⁴ copies/μL for each target, 100% specificity, and perfect concordance with individual cPCR assays when testing 197 fecal samples from northeast China [5]. While valuable for epidemiological screening, the analytical sensitivity of this mPCR is lower than that of qPCR platforms.

To address the need for both high sensitivity and multiplex capability, Zou et al. (2022) established a TaqMan-based multiplex real-time PCR for simultaneous detection of FBoV-1, FeAstV, FeKoV (feline kobuvirus), and FPV [16]. The detection limit of the single-plex qPCR was 10 copies per reaction, while the multiplex format achieved 100 copies per reaction, with correlation coefficients exceeding 0.995 for all targets. Applied to 135 clinical samples, this assay revealed a 25.19% rate of co-infection among these four viruses, including a 1.48% quadruple infection rate [16]. This high-throughput, quantitative approach is particularly advantageous for diagnostic laboratories managing large caseloads and for research investigating the synergistic effects of viral co-infections on disease severity, a phenomenon hypothesized in the context of FBoV and FPLV co-infections leading to hemorrhagic enteritis outbreaks [7, 15]. The ability to discriminate and quantify multiple agents from a single sample reduces diagnostic turnaround time, conserves sample material, and provides a comprehensive virological profile that is essential for clinical decision-making and outbreak investigations.

In Situ Hybridization, Immunohistochemistry, and Electron Microscopy

While molecular detection in feces and blood is the mainstay of FBoV diagnosis, understanding viral tropism and pathogenesis requires localization of viral nucleic acid and protein within tissues. In situ hybridization (ISH) using probes targeting FBoV-specific sequences has been instrumental in defining the cellular targets of infection. Piewbang et al. (2019) utilized ISH to detect FBoV-1 DNA in intestinal epithelial cells, vascular endothelium of the intestinal mucosa and serosa, and necrotic areas within lymph nodes of cats with hemorrhagic enteritis [7]. This work demonstrated that FBoV-1 can cause systemic infection with viral nucleic acid present in multiple organs, supporting the hypothesis that hematogenous dissemination occurs following enteric infection.

In a groundbreaking neuropathological investigation, Piewbang et al. (2022) employed ISH with dual labeling using Olig-2 (oligodendrocyte marker) and NeuN (neuronal marker) immunohistochemistry to demonstrate FBoV-1 and FBoV-3 DNA within oligodendroglia and vacuolated neurons of cats with neurologic deficits [4]. The study further confirmed the presence of FBoV-3 virions within the nuclei of glial cells using transmission electron microscopy (TEM), providing ultrastructural evidence of productive infection in the central nervous system [4]. These histopathological and ultrastructural methods, while not suitable for routine clinical diagnosis, are indispensable for establishing causal relationships between FBoV infection and specific pathological lesions, such as neuronal vacuolation, eosinophilic intranuclear inclusion bodies, and multifocal inflammatory responses observed in naturally infected cats [4, 7].

Metagenomics and Next-Generation Sequencing

The advent of unbiased metagenomic sequencing has transformed the discovery and surveillance of feline enteric viruses, including FBoV. Brussel et al. (2022) employed meta-transcriptomic and viral particle enrichment metagenomic approaches to characterize the eukaryotic enteric virome of 23 cats naturally infected with FPV and 36 healthy controls [15]. This approach revealed that Carnivore bocaparvovirus 3 (FBoV-1) and Carnivore bocaparvovirus 4 (FBoV-2) were among the most abundant and frequently detected viruses, with FBoV-2 and FBoV-3 detected significantly more frequently in FPV-positive cats than in healthy controls [15]. Metagenomics also identified co-infections with FCoV, FeAstV, and feline kobuvirus at rates that would be difficult to achieve using targeted PCR alone. This technology provides a hypothesis-free, comprehensive snapshot of the entire viral community within a sample, enabling the detection of novel or divergent strains that might be missed by genotype-specific primers. Although currently cost-prohibitive for routine diagnostics, metagenomic sequencing is increasingly employed in reference laboratories and research settings to monitor viral evolution, detect recombination events, and elucidate the complex interactions among enteric viruses that may influence clinical outcomes.

Shedding Dynamics, Persistence, and Transmission in Multi-Cat Environments

The elucidation of shedding dynamics, environmental persistence, and transmission pathways for feline bocavirus (FBoV) is paramount for understanding its epizootiology and implementing effective infection control strategies, particularly within the complex ecological niche of multi-cat environments. Unlike solitary household pets, cats residing in shelters, breeding catteries, and multi-cat households experience heightened population density, frequent introduction of new individuals, and elevated stress levels, all factors that can profoundly alter viral shedding kinetics and facilitate sustained pathogen circulation. The following analysis synthesizes the current body of evidence, drawing heavily from longitudinal surveillance, quantitative viral load studies, and molecular epidemiological investigations to construct a comprehensive model of FBoV transmission dynamics.

Quantitative Shedding Profiles and Temporal Dynamics

The cornerstone of understanding FBoV transmission lies in the quantitative assessment of viral shedding over time. The seminal prospective investigation by Lohavicharn et al. (2025) [1] provides the most detailed characterization of FBoV shedding dynamics in naturally infected cats to date. Utilizing species-specific TaqMan-based quantitative PCR (qPCR) assays for FBoV-1, FBoV-2, and FBoV-3, this study monitored seven symptomatic cats across three distinct multi-cat households over multiple time points. The results revealed a striking heterogeneity in viral load trajectories. In several cats, qPCR demonstrated that viral nucleic acid concentrations fluctuated significantly over the course of infection, with peak shedding often coinciding with the acute phase of gastrointestinal signs but not invariably so. Critically, the study documented that positive viral detection persisted for 10–14 days after the complete resolution of clinical signs in the majority of cases. This post-convalescent shedding phase represents a critical window for silent transmission, as apparently healthy cats continue to excrete infectious virions into the environment. Even more alarming was the observation that one hospital-resident cat continued to shed FBoV-1 for up to 65 days [1]. This extraordinary duration of shedding, far exceeding the typical clinical illness period, suggests that FBoV can establish a prolonged carrier state in certain individuals, potentially serving as a persistent reservoir within closed populations.

The quantitative nature of these findings is further supported by the development of highly sensitive molecular tools. Wang et al. (2020) established a TaqMan-based qPCR for FBoV-1 with a detection limit of 4.57 × 10¹ copies/μL, demonstrating 100-fold greater sensitivity than conventional PCR [17]. Similarly, a SYBR Green I-based qPCR achieved a detection limit of 3.87 × 10¹ copies/μL [6]. These methodological advances have enabled researchers to detect low-level shedding that would be missed by endpoint PCR, revealing that subclinical shedders may be far more common than previously appreciated. The application of such sensitive assays in multi-cat settings is essential, as the difference between a cat shedding 10² versus 10⁶ viral copies per gram of feces has profound implications for environmental contamination and transmission risk.

Route-Specific Shedding and Tissue Tropism

Understanding the routes by which FBoV is shed is critical for designing targeted biosecurity interventions. The available evidence points to a multifaceted shedding profile involving both enteral and parenteral routes. The longitudinal study by Lohavicharn et al. employed route-specific sampling, demonstrating that FBoV DNA could be detected in fecal samples, but also raised the possibility of shedding via other bodily secretions [1]. This is consistent with the broader tropism of bocaviruses, which are known to infect respiratory and gastrointestinal epithelia in other species.

The neurotropic potential of FBoV, as demonstrated by Piewbang et al. (2022), adds another layer of complexity to shedding dynamics. In cats with neurological deficits, FBoV DNA was detected not only in brain tissues (cerebrum, brain stem, and occasionally cerebellum) but also in multiple lymph nodes (5/5 cases) and intestinal tissues (2/5 cases) [4]. The detection of viral DNA in lymph nodes suggests a lymphoid tropism that may facilitate systemic dissemination and shedding from multiple mucosal sites. The presence of FBoV in intestinal tissues of neurologically affected cats confirms that even in cases of systemic infection, fecal-oral shedding remains a primary route of transmission. The in situ hybridization studies revealing FBoV DNA in oligodendroglia and vacuolated neurons [4] further underscore that viral replication is not restricted to the gut, and that shedding may occur from the central nervous system under specific circumstances, although the clinical significance of this for horizontal transmission remains speculative.

The pathological investigations by Piewbang et al. (2019) during outbreaks of hemorrhagic enteritis provided critical insights into viral tropism at the tissue level. Using in situ hybridization, FBoV-1 nucleic acid was localized to intestinal epithelial cells, vascular endothelium of the intestinal mucosa and serosa, and necrotic areas within lymph nodes [7]. This dual tropism for enterocytes and vascular endothelium explains the efficient fecal shedding observed clinically and also suggests that viremia is a common feature of infection, potentially leading to shedding in urine or saliva. The detection of FBoV DNA in multiple tissues, including lymph nodes and intestines, of cats with neurological disease [4] reinforces the concept that FBoV is not an exclusively enteric pathogen but rather a systemic virus with a predilection for lymphoid and neural tissues, which may influence shedding patterns.

Environmental Persistence and Fomite Transmission

The physical and chemical properties of FBoV, as a member of the Parvoviridae family, are paramount to understanding its environmental persistence. Parvoviruses are renowned for their exceptional stability in the environment, being non-enveloped, single-stranded DNA viruses that are resistant to heat, desiccation, and many common disinfectants. Although specific data on FBoV environmental survival are lacking, extrapolation from closely related parvoviruses, such as feline panleukopenia virus (FPV) and canine parvovirus type 2 (CPV-2), is instructive. These viruses can persist for months to years on contaminated surfaces, bedding, food bowls, and litter boxes at room temperature, and are resistant to quaternary ammonium compounds and alcohol-based sanitizers. The World Organisation for Animal Health (WOAH) recognizes parvoviruses as highly environmentally resilient pathogens that require rigorous disinfection protocols, including the use of bleach (sodium hypochlorite) or accelerated hydrogen peroxide, for effective inactivation.

In multi-cat environments, this environmental stability creates a persistent reservoir of infectious virus. Fomite transmission via contaminated litter boxes, grooming tools, bedding, and human hands is likely a major route of spread. The high viral loads detected in feces [1, 6, 17] mean that even microscopic fecal contamination can deposit thousands of infectious particles onto surfaces. The prolonged shedding observed post-recovery [1] further compounds this problem, as clinically normal cats are continuously contaminating the environment. Shelters and catteries must therefore consider that FBoV can be introduced by asymptomatic carriers and can persist in the environment long after an outbreak appears to have resolved.

Transmission Dynamics in Multi-Cat Households and Shelters

The epidemiological data from multi-cat settings provide compelling evidence for efficient horizontal transmission. In the study by Lohavicharn et al., FBoV-1 and FBoV-2 were detected in multiple cats within a single household (House A), with coinfection observed in 55.6% (5/9) of cats [1]. This high rate of within-household transmission suggests that once FBoV is introduced, it spreads rapidly among susceptible contacts. The detection of FCoV as a frequent codetection in all households [1] is particularly noteworthy, as feline coronavirus is also highly prevalent in multi-cat environments and shares similar transmission routes (fecal-oral). The synergistic interaction between these two viruses may facilitate co-transmission or enhance shedding of one or both pathogens.

The prevalence data from China further illuminate transmission dynamics. Yi et al. (2018) reported an overall FBoV prevalence of 25.9% (51/197) in fecal samples from Northeast China, with a significantly higher positive rate in cats with diarrhea (33.3%, 35/105) compared to normal cats (17.4%, 16/92) [11]. This suggests that while subclinical infection is common, diarrheic cats shed virus at higher rates or for longer durations, making them more effective transmitters. The detection of FBoV-1 and FBoV-2 co-circulating in the same population [11] indicates that multiple genotypes can be maintained simultaneously, potentially through sequential infections or mixed infections in individual cats. The study by Yao et al. (2024) in Harbin, China, detected FBoV in 12.1% of blood samples from healthy cats, with genotypes 1 and 3 co-circulating [3]. The detection of FBoV in blood confirms that viremic cats are present in the population, and these individuals may shed virus through multiple routes.

The role of age in transmission dynamics is critical. Ogata et al. (2025) demonstrated that in rescued stray cats in Japan, FBoV-1 and FBoV-2 were significantly more prevalent in cats with diarrhea, and that kittens aged 1–2 months had a significantly higher rate of diarrhea symptoms than older cats [13]. This age-dependent susceptibility has profound implications for multi-cat environments where kittens are present, such as breeding catteries and shelters with neonatal wards. Kittens, with their immature immune systems and high susceptibility, can serve as amplifiers of infection, shedding large quantities of virus and contaminating the environment for older, more resistant cats.

Genotypic Diversity and Its Impact on Shedding

The existence of three distinct FBoV genotypes (FBoV-1, -2, and -3) with varying genetic diversity and potential differences in pathogenicity complicates the shedding picture. The study by Lohavicharn et al. found that FBoV-1 and FBoV-2 co-circulated in the same household, while only FBoV-1 was identified in other households [1]. This suggests that different genotypes may have different transmission efficiencies or that prior immunity to one genotype does not protect against infection with another. The genetic characterization of Thai FBoV strains by Lohavicharn et al. (2024) revealed that recombination breakpoints are commonly found in the NP1 and VP1/2 genes, which are critical for capsid structure and host cell interaction [14]. Recombination events could alter viral tropism, shedding efficiency, or environmental stability, leading to the emergence of strains with enhanced transmission capabilities.

The detection of recombinant FBoV strains in China [3, 8] and Thailand [14] indicates that genetic exchange is an ongoing process that could generate novel variants with unpredictable shedding profiles. The presence of both inter- and intra-genotype recombination [8] suggests that coinfection with multiple genotypes in the same host is not rare, and that such coinfected individuals may shed a mixture of parental and recombinant viruses, further complicating transmission dynamics.

Implications for Infection Control

The shedding dynamics described above have direct and actionable implications for managing FBoV in multi-cat environments. First, the prolonged shedding period (10–14 days post-recovery, and up to 65 days in some cases) [1] mandates that isolation protocols for clinically affected cats should extend well beyond the resolution of clinical signs. A minimum isolation period of 14 days after the last diarrheic episode is prudent, but given the potential for prolonged shedding, qPCR testing to confirm negativity before reintroduction to the general population is strongly recommended.

Second, the high prevalence of subclinical shedders [11] means that quarantine of new arrivals is essential. Even apparently healthy cats can introduce FBoV into a naïve population. A quarantine period of at least 2–3 weeks, combined with molecular screening, is advisable for shelters and catteries.

Third, the environmental persistence of parvoviruses necessitates rigorous disinfection protocols. Bleach (1:32 dilution of household bleach, or 0.5% sodium hypochlorite) with a contact time of at least 10 minutes is effective against parvoviruses. Potassium peroxymonosulfate (e.g., Virkon S) and accelerated hydrogen peroxide products are also effective. Litter boxes should be made of non-porous materials and disinfected daily. Bedding and food bowls should be washed in hot water with bleach.

Fourth, the age-dependent susceptibility [13] highlights the need for special protection of kittens. In breeding catteries, queens should be vaccinated against FPV (which may provide some cross-protection or at least reduce coinfections), and kittens should be kept in clean, disinfected environments until they are at least 4 months old.

Finally, the frequent codetection of FCoV with FBoV [1] suggests that control measures targeting one virus may inadvertently impact the other. Reducing fecal-oral transmission through improved hygiene and reduced crowding will decrease the force of infection for both pathogens. The use of probiotics or immunomodulators to enhance mucosal immunity may also be beneficial, although specific data for FBoV are lacking.

In summary, FBoV shedding is characterized by high viral loads, prolonged duration, and a significant subclinical component. The virus is environmentally robust and transmits efficiently via the fecal-oral route in multi-cat settings. Effective control requires a multifaceted approach combining extended isolation, rigorous disinfection, quarantine of new arrivals, and protection of age-susceptible groups. The ongoing genetic evolution of FBoV through recombination necessitates continued surveillance to detect the emergence of strains with altered shedding or transmission characteristics.

References

[1] Lohavicharn P, Kitnitchee M, Kasantikul T, Tummaruk P, Piewbang C, Techangamsuwan S. Prospective investigation of feline bocavirus persistence and shedding in naturally infected cats from varied household settings. Journal of feline medicine and surgery. 2025. DOI: https://doi.org/10.1177/1098612X251384767

[2] Dong HV, Tran G, Nguyen YHT, Ngo TC, Rattanasrisomporn A, Boonkaewwan C, et al.. Co-circulation and genetic characterization of genotype I and II feline bocavirus strains in domestic cats from Northern Vietnam. Veterinary World. 2025. DOI: https://doi.org/10.14202/vetworld.2025.1590-1598

[3] Yao X, Shi B, Li H, Han Y, Zhong K, Shao J, et al.. Epidemiology and genotypic diversity of feline bocavirus identified from cats in Harbin, China.. Virology. 2024. DOI: https://doi.org/10.1016/j.virol.2024.110188

[4] Piewbang C, Wardhani SW, Phongroop K, Lohavicharn P, Sirivisoot S, Kasantikul T, et al.. Naturally acquired feline bocavirus type 1 and 3 infections in cats with neurologic deficits.. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14664

[5] Zhang Q, Niu J, Yi S, Dong G, Yu D, Guo Y, et al.. Development and application of a multiplex PCR method for the simultaneous detection and differentiation of feline panleukopenia virus, feline bocavirus, and feline astrovirus. Archives of Virology. 2019. DOI: https://doi.org/10.1007/s00705-019-04394-8

[6] Wang Y, Li W, Guo X, Zhang D, Sun J, Fu Z, et al.. Development of SYBR Green I-based polymerase chain reaction for feline bocavirus 1 detection. 3 Biotech. 2021. DOI: https://doi.org/10.1007/s13205-020-02577-8

[7] Piewbang C, Kasantikul T, Pringproa K, Techangamsuwan S. Feline bocavirus-1 associated with outbreaks of hemorrhagic enteritis in household cats: potential first evidence of a pathological role, viral tropism and natural genetic recombination. Scientific Reports. 2019. DOI: https://doi.org/10.1038/s41598-019-52902-2

[8] Wang Y, Guo X, Li W, Cui Y, Zhang D, Xu F, et al.. Phylogenetic analysis and evolution of feline bocavirus in Anhui Province, eastern China.. Comparative Immunology, Microbiology & Infectious Diseases. 2021. DOI: https://doi.org/10.1016/j.cimid.2021.101676

[9] Wang Y, Pan Y, Wu J, Tong X, Sun J, Xu F, et al.. Simultaneous detection of feline parvovirus and feline bocavirus using SYBR Green I-based duplex real-time polymerase chain reaction. 3 Biotech. 2021. DOI: https://doi.org/10.1007/s13205-021-02947-w

[10] Liu C, Liu F, Li Z, Qu L, Liu D. First report of feline bocavirus associated with severe enteritis of cat in Northeast China, 2015. Journal of Veterinary Medical Science. 2018. DOI: https://doi.org/10.1292/jvms.17-0444

[11] Yi S, Niu J, Wang H, Dong G, Zhao Y, Dong H, et al.. Detection and genetic characterization of feline bocavirus in Northeast China. Virology Journal. 2018. DOI: https://doi.org/10.1186/s12985-018-1034-3

[12] Takano T, Takadate Y, Doki T, Hohdatsu T. Genetic characterization of feline bocavirus detected in cats in Japan. Archives of Virology. 2016. DOI: https://doi.org/10.1007/s00705-016-2972-y

[13] Ogata M, Iyoda M, Soma T. Infection with novel feline parvoviruses in rescued stray cats in Japan. Journal of Veterinary Medical Science. 2025. DOI: https://doi.org/10.1292/jvms.24-0337

[14] Lohavicharn P, Kasantikul T, Piewbang C, Techangamsuwan S. Feline bocaviruses found in Thailand have undergone genetic recombination for their evolutions.. Infection, Genetics and Evolution. 2024. DOI: https://doi.org/10.1016/j.meegid.2024.105675

[15] Brussel KV, Wang X, Shi M, Carrai M, Feng S, Li J, et al.. The enteric virome of cats with feline panleukopenia differs in abundance and diversity from healthy cats. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14646

[16] Zou J, Yu J, Mu Y, Xie X, Wang R, Wu H, et al.. Development of a TaqMan-based multiplex real-time PCR for simultaneous detection of four feline diarrhea-associated viruses. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.1005759

[17] Wang Y, Sun J, Guo X, Zhang D, Cui Y, Li W, et al.. TaqMan-based real-time polymerase chain reaction assay for specific detection of bocavirus-1 in domestic cats. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101647

[18] Niu J, Yi S, Wang H, Dong G, Zhao Y, Guo Y, et al.. Complete genome sequence analysis of canine bocavirus 1 identified for the first time in domestic cats. Archives of Virology. 2018. DOI: https://doi.org/10.1007/s00705-018-4096-z

[19] Putri R, Wahyuwardani S. Koinfeksi pada Kejadian Panleukopenia Kucing: Suatu Kajian Pustaka. Jurnal Veteriner. 2022. DOI: https://doi.org/10.19087/jveteriner.2022.23.1.121

[20] Abayli H, Yalçinkaya E, Tonbak S, Aslan AN. Sustained circulation of genotype I and the first whole-genome sequencing of feline calicivirus in Turkish cats. BMC Veterinary Research. 2026. DOI: https://doi.org/10.1186/s12917-026-05352-8

[21] Yi S, Niu J, Wang H, Dong G, Guo Y, Dong H, et al.. Molecular characterization of feline astrovirus in domestic cats from Northeast China. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0205441

[22] Wang J, Yan Z, Liu H, Wang W, Liu Y, Zhu X, et al.. Prevalence and Molecular Evolution of Parvovirus in Cats in Eastern Shandong, China, between 2021 and 2022. Transboundary and Emerging Diseases. 2024. DOI: https://doi.org/10.1155/2024/5514806

[23] Niu T, Yi S, Wang X, Wang L, Guo B, Zhao L, et al.. Detection and genetic characterization of kobuvirus in cats: The first molecular evidence from Northeast China. Infection, Genetics and Evolution. 2018. DOI: https://doi.org/10.1016/j.meegid.2018.12.010